Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Mouse CD154 (Bp50, TNFRSF5, CD40) In Vivo PLATINUM; Clone FGK4.5; Isotype: Rat IgG2a
SDP

Supplier:  Leinco Technologies Inc F11951.0 MG

Encompass_Preferred

Specificity: Clone FGK4.5 recognizes an epitope on mouse CD40. Antigen Distribution: CD40 is expressed on B cells, basal epithelial cells, macrophages, follicular dendritic cells, and endothelial cells. Background: CD40 is a 48 kD type I transmembrane glycoprotein and part of the TNFR superfamily. CD40 is involved in the proliferation and differentiation of B cells and is critical for Ig class switching. The membrane-anchored CD40L is expressed almost exclusively on activated CD4+ T lymphocytes. CD40L is thought to play a part in the pathogenesis of some diseases including immunodeficiency with hyper-IgM and Alzheimer Disease. Applications: (WB, FA) Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-6289


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.